Bio-Techne (TECH) Misses Q4 EPS by 8c, Revenues Miss

August 6, 2019 6:45 AM

Bio-Techne (NASDAQ: TECH) reported Q4 EPS of $1.25, $0.08 worse than the analyst estimate of $1.33. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found